Department of Pathological Anatomy

Medicine & Life Sciences

1. Adenocarcinoma 10%
2. Annona 7%
3. Anti-Inflammatory Agents 7%
4. antimycin 7%
5. Apoptosis 14%
6. Azoxymethane 7%
7. B-Lymphocytes 8%
8. Basal Cell Carcinoma 6%
9. Biopsy 12%
10. Bone and Bones 15%
11. Breast 6%
12. Breast Neoplasms 43%
13. Cadherins 6%
14. Cancer Care Facilities 6%
15. Cancer-Associated Fibroblasts 6%
16. Carcinogenesis 10%
17. Carcinoma 20%
18. Case-Control Studies 7%
19. Caspase 3 14%
20. Catenins 10%
21. Cell Biology 10%
22. Cell Line 15%
23. Cell Proliferation 7%
24. Chitosan 6%
25. Chronic Hepatitis B 6%
26. Colon 17%
27. Colorectal Neoplasms 23%
28. Control Groups 11%
29. Cross-Sectional Studies 6%
30. Curcumin 6%
31. Cyclooxygenase 2 7%
32. Dextran Sulfate 19%
33. DNA 6%
34. Drug Therapy 12%
35. Ductal Carcinoma 7%
36. Embryonal Rhabdomyosarcoma 6%
37. Endometrioid Carcinoma 6%
38. Eosine Yellowish-(YS) 6%
39. Epidemiologic Studies 7%
40. Epidemiology 6%
41. Ethanol 10%
42. Fetal Blood 5%
43. Fibrosis 8%
44. Fruit 7%
45. Genes 6%
46. Giant Cell Tumor of Bone 8%
47. Giant Cell Tumors 7%
48. Growth 5%
49. Hematoxylin 6%
50. Hepatocellular Carcinoma 8%
51. Human Herpesvirus 4 12%
52. Immunohistochemistry 19%
53. In Vitro Techniques 6%
54. Incidence 7%
55. Indonesia 100%
56. Inflammation 9%
57. Japan 12%
58. Keratin-19 6%
59. Liver 11%
60. Lymph Nodes 13%
61. Lymphocytes 7%
62. Lymphoma 15%
63. Lymphoma, Large B-Cell, Diffuse 13%
64. Melanoma 8%
65. Mesenchymal Stem Cells 8%
66. Mitosis 6%
67. Mutation 9%
68. Natural Killer Cells 6%
69. Neoplasm Metastasis 20%
70. Neoplasms 41%
71. Neoplastic Stem Cells 6%
72. nucleolar organizer region associated proteins 6%
73. Osteosarcoma 9%
74. Ovarian Neoplasms 5%
75. Paraffin 9%
76. Pathology 9%
77. Pleural Empyema 12%
78. Polymerase Chain Reaction 5%
79. Polyps 6%
80. Pomegranate 6%
81. Population 7%
82. Proteins 12%
83. Radiotherapy 6%
84. Recurrence 7%
85. Rhabdomyosarcoma 6%
86. Sarcoma 8%
87. Sensitivity and Specificity 6%
88. Skin 7%
89. Skin Neoplasms 15%
90. Sprague Dawley Rats 7%
91. Squamous Cell Carcinoma 14%
92. Staining and Labeling 17%
93. Survival 9%
94. T-Cell Lymphoma 10%
95. Therapeutics 9%
96. Tuberculosis 7%
97. Uterine Cervical Neoplasms 28%
98. Wistar Rats 7%
99. Wound Healing 6%
100. Wounds and Injuries 6%